Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0021 Transporter Info | ||||
| Gene Name | SLC15A1 | ||||
| Transporter Name | Peptide transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Cefoxitin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 441199 | ||||
| Docking Score | -6.219 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H17N3O7S2 | ||||
| Molecular Weight | 427.5 | ||||
| Canonical SMILES |
CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3
|
||||
| InChI |
InChI=1S/C16H17N3O7S2/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22)/t14-,16+/m1/s1
|
||||
| InChIKey | WZOZEZRFJCJXNZ-ZBFHGGJFSA-N | ||||
| Pharmaceutical Properties | Xlogp | 0 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 9 | ||
| Xenobiotic Name | MDL-28170 Drug Info | ||||
| Xenobiotic Type | Discontinued Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 72430 | ||||
| Docking Score | -6.191 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C22H26N2O4 | ||||
| Molecular Weight | 382.5 | ||||
| Canonical SMILES |
CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C=O)NC(=O)OCC2=CC=CC=C2
|
||||
| InChI |
InChI=1S/C22H26N2O4/c1-16(2)20(24-22(27)28-15-18-11-7-4-8-12-18)21(26)23-19(14-25)13-17-9-5-3-6-10-17/h3-12,14,16,19-20H,13,15H2,1-2H3,(H,23,26)(H,24,27)/t19-,20-/m0/s1
|
||||
| InChIKey | NGBKFLTYGSREKK-PMACEKPBSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.7 | Rotatable Bond Count | 10 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | ||
| Xenobiotic Name | Loracarbef Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5284585 | ||||
| Docking Score | -6.15 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H16ClN3O4 | ||||
| Molecular Weight | 349.77 | ||||
| Canonical SMILES |
C1CC(=C(N2[C@H]1[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)Cl
|
||||
| InChI |
InChI=1S/C16H16ClN3O4/c17-9-6-7-10-12(15(22)20(10)13(9)16(23)24)19-14(21)11(18)8-4-2-1-3-5-8/h1-5,10-12H,6-7,18H2,(H,19,21)(H,23,24)/t10-,11-,12+/m1/s1
|
||||
| InChIKey | JAPHQRWPEGVNBT-UTUOFQBUSA-N | ||||
| Pharmaceutical Properties | Xlogp | -1.7 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.